INTRODUCTION
The incidence of systemic and mucosal infections caused by species of the genus Candida has increased dramatically in recent decades. Candida albicans is considered the most pathogenic species of the genus Candida, and the most common cause of deep and superficial candidiasis (Coleman et al., 1997b) . In addition to the elevated prevalence of infections caused by C. albicans, other species such as Candida glabrata, Candida tropicalis, Candida dubliniensis, Candida parapsilosis, Candida krusei and Candida guilliermondii are also associated with invasive candidiasis in humans (Krcmery & Barnes, 2002) .
C. dubliniensis is an opportunistic yeast of the genus
Candida associated primarily with oral candidiasis Sullivan et al., 1995) in human patients infected with human immunodeficiency virus (HIV) or with AIDS (Gugnani et al., 2003; Patel et al., 2012; Sullivan et al., 2004) . In addition, this species has been described to a lesser extent in healthy individuals and people not infected with HIV, but affected by severe underlying illnesses such as diabetes, cystic fibrosis or cancer (Coleman et al., 1997b; Dahiya et al., 2003; Davies et al., 2002; Lai et al., 2013; Manfredi et al., 2002; Parmeland et al., 2013; Peltroche-Llacsahuanga et al., 2002; Willis et al., 2000; Yu et al., 2012) . methods. In order to distinguish between these two Candida species, several identification assays, with varying degrees of accuracy, are available based on phenotypic, genotypic and immunological differences. Phenotypic tests, such as the ability to grow at different temperatures, colony colour and morphology on chromogenic media, chlamydospore production or carbohydrate assimilation tests, are widely used as routine assays in clinical microbiology laboratories. In addition, a commercial test (Bichro-Dubli Fumouze) to identify C. dubliniensis isolates by latex agglutination using beads sensitized with a highly specific mAb (12F7-F2) (Marot-Leblond et al., 2006) is currently available. However, the most accurate and reliable tests to discriminate between C. dubliniensis and C. albicans are those based on DNA analysis, such as DNA amplification by PCR with specific primers and DNA sequencing applied to the rRNA gene cluster (Donnelly et al., 1999; Ellepola et al., 2003) .
Here, we report on a population study with 477 clinical isolates of Candida spp. where 434 of them were identified as C. albicans, 34 isolates were C. dubliniensis and nine isolates showed anomalous patterns on various routine identification assays. DNA analysis allowed the unambiguous identification of all these uncommon isolates as C. dubliniensis, whose phenotypic and genotypic properties are discussed in this work.
METHODS
Isolates and culture conditions. A total of 477 clinical isolates of Candida spp. recovered from different anatomical sites (oral mucosa, blood, respiratory tract) of patients from disparate geographical locations were included in this study. Amongst these were 434 C. albicans and 34 C. dubliniensis isolates as well as nine atypical isolates which we were unable to identify using routine diagnostic tests due to their unusual phenotype.
The geographical and clinical origins of the nine unusual isolates identified amongst this strain collection are listed in Table 1 . Group I isolates (n53) were collected from the oral cavity of three separate HIV-infected patients in Spain and group II isolates (n56) were collected from the oral cavity of six different individuals with gingival or periodontal disorders in Argentina. Reference strains for identification tests included C. dubliniensis NCPF 3949 obtained from the National Collection of Pathogenic Fungi (Bristol, UK) and C. albicans SC5314 obtained from the Stanford DNA Sequencing and Technology Center (Stanford, CA, USA). Reference strains belonging to C. dubliniensis genotypes 1, 2, 3 and 4 were, respectively, NCPF 3949, CBS 2747 obtained from the Centraalbureau Voor Schimmelcultures (Utrecht, The Netherlands), and clinical isolates p6265 and p7718 (Gee et al., 2002) obtained from Dublin Dental University Hospital. Yeasts were grown routinely on Sabouraud dextrose agar (SDA; Difco) for 24-48 h at 37 uC.
Phenotypic analyses. Germ tube tests were performed in FBS (Sigma) either concentrated or diluted with varying amounts of 0.65 % (w/v) yeast nitrogen base minimal medium without amino acids (YNB; Difco) containing 5 % (w/v) glucose. One million yeast cells were inoculated in 0.5 ml pure or diluted FBS, incubated at 37 uC for 3 h and germ tube formation was observed by microscopy.
The ability of isolates to grow at elevated temperature was determined by examining their ability to grow on SDA plates incubated at 45 uC for 24-48 h.
Chlamydospore production was examined by incubating the isolates for 72 h at 30 uC on Pal's agar (Pal, 1997) , Staib agar (Staib & Morschhäuser, 1999) , Casein agar (Mosca et al., 2003) , Cornmeal agar (Sullivan et al., 1995) , CHROM-Pal's agar (CH-P) (Sahand et al., 2005) , and YNB agar supplemented with galactose 0.025 % (w/v) and methionine (25-100 mg l 21 ) (Citiulo et al., 2009 ).
Isolates were also cultured on a range of chromogenic media such as CHROMagar Candida (CAC; CHROMagar), CH-P and ChromID Candida chromogenic media (ChromID; bioMérieux) at 30 (CH-P) or 37 uC (CAC and ChromID) for 48 h.
Phenotypic variability of the colonies was also examined on SDA supplemented with phloxine B (5 mg l
21
; Sigma) (Lipperheide et al., 2002) . Plates were inoculated with~100 cells and incubated for up to 10 days at 37 uC.
Carbohydrate assimilation profiles were determined by using the API/ ID32C yeast identification system (bioMérieux), according to the manufacturer's instructions.
Immunological characterization. The Bichro-Dubli Fumouze latex agglutination test (Fumouze Diagnostics) for identification of C. dubliniensis strains was performed according to the manufacturer's instructions (Sahand et al., 2006) . Indirect immunofluorescence assays (IFAs) were performed as described by Bikandi et al. (1998) using a purified preparation of mAb 12F7-F2 (1.49 mg ml
) kindly provided by Dr Raymond Robert (Angers, France) and a polyclonal anti-C. dubliniensis serum raised in a rabbit infected with C. dubliniensis which was adsorbed 1 : 1 with formalin-fixed C. albicans NCPF 3153 blastospores as also described by Bikandi et al. (1998) . Briefly, blastospores were grown on SDA plates for 48 h at 24 uC, resuspended in PBS at a cell density of 10 6 cells ml 21 and fixed on Teflon-coated immunofluorescence slides. These slides were incubated DNA extraction. Yeast genomic DNA was extracted as described by Hoffman & Winston (1987) , with minor modifications. Briefly, yeast cells were grown overnight in 5 ml Sabouraud broth at 37 uC and 120 r.p.m. in a Gallenkamp orbital shaker incubator (Gemini). An aliquot of 1.5 ml culture was harvested by centrifugation at 14 000 r.p.m. (Heraeus Biofuge Pico microcentrifuge; DJB Labcare) and the pellet was washed twice with sterile MilliQ water. Cells were lysed in 200 ml breaking buffer (2 %, v/v, Triton X-100, 1 %, w/v, SDS, 100 mM NaCl, 10 mM Tris/HCl, pH 8.0 and 1 mM EDTA, pH 8.0) by vortexing with 0.3 g glass beads (0.5 mm diameter; Sigma) five times for 1 min separated by identical intervals of cooling on ice. Then, 500 ml phenol/chloroform/isoamyl alcohol (25 : 24 : 1; Sigma) solution was added to the lysate and the mixture was homogenized vigorously for 30 s. At this point, samples were centrifuged at 14 000 r.p.m. for 10 min (Heraeus Biofuge Pico microcentrifuge) and the upper layer was transferred to a new vial containing 200 ml phenol/chloroform/isoamyl alcohol (25 : 24 : 1) solution. The mixture was homogenized and centrifuged again at 14 000 r.p.m. for 3 min. The upper phase was collected and after the addition of 20 ml 3 M sodium acetate and 400 ml cold ethanol (220 uC), the vials were inverted several times until precipitated DNA was visualized. Subsequently, the samples were centrifuged for 5 min at 14 000 r.p.m. and the supernatants decanted. Pellets were resuspended in 1 ml cold 70 % ethanol and centrifuged for 1 min at 14 000 r.p.m. Supernatants were decanted again and DNA pellets were resuspended in 50 ml TE buffer (10 mM Tris/HCl, pH 8.0 and 1 mM EDTA, pH 8.0).
Genotypic characterization. Further characterization of test isolates was conducted using multiplex PCR amplification with two pairs of specific primers. One pair of primers, CALB1F and CALB2R, specific for C. albicans, amplified a fragment of 273 bp from the internal transcribed spacer (ITS) regions ITS1 and ITS2 of the rRNA genes (Luo & Mitchell, 2002) , whilst the second pair, CDBF28F and CDBR110R highly specific for C. dubliniensis, amplified an 816 bp fragment of the topoisomerase II gene (Kanbe et al., 2003) . In addition, a conventional PCR assay was performed to discriminate amongst Candida africana, C. albicans and C. dubliniensis by means of a set of primers (CR-f and CR-r) derived from the HWP1 gene as described by Romeo & Criseo (2008) .
The identity of the isolates tested was assigned by sequencing the large subunit rRNA D1/D2 domain after amplification with NL1 and NL4 primers as described by Kurtzman & Robnett (1998) . Sequence alignment was performed using the BLAST (www.ncbi.nlm.nih.gov/ blast/). The assignment of genotype for the C. dubliniensis isolates was performed by PCR with primers G1F/G1R, G2F/G2R, G3F/G3R and G4F/G4R according to the method of Gee et al. (2002) as described by Brena et al. (2004) , and the four reference strains of C. dubliniensis genotypes 1, 2, 3 and 4 (NCPF 3949, CBS 2747, p6265 and p7718, respectively) were used as positive controls.
In order to determine the genotype of the uncommon C. dubliniensis isolates at the MTL (mating type like) locus, a multiplex PCR using two pairs of specific primers was performed as described by Rustad et al. (2002) . One pair of primers, MTLa1-F and MTLa1-R, amplified a fragment of 535 bp and the second pair, MTLa1-F and MTLa1-R, rendered a product of 615 bp. ). Each well incorporated the fluorescent dye Alamar Blue (resazurin), which turned from blue to pink when microbial growth occurred.
RESULTS
A total of 477 clinical isolates first identified as C. albicans that had been recovered from different anatomical sites (oral mucosa, blood, respiratory tract) of patients from disparate geographical locations were revised in order to investigate the prevalence of C. dubliniensis amongst them. By so doing, 34 strains mostly isolated from oral samples were renamed as C. dubliniensis. During this process we also found nine additional oral isolates with unusual phenotypic traits which hampered their definitive identification (Table 1) . Further characterization of these nine isolates was performed with several phenotypic, genotypic and immunological assays, and the results obtained were matched against reference strains of C. dubliniensis and C. albicans.
Phenotypic characteristics
A summary of the results obtained in the phenotypic analysis of the nine isolates is shown in Table 2 . Whilst all nine isolates grew well as smooth creamy white colonies at 30 and 37 u C on SDA medium, they did not show signs of growth when incubated at 45 u C. When examined microscopically, six isolates (08-15-08-20) formed round and ovoid blastospores, similar to those of the reference strains C. dubliniensis NCPF 3949 and C. albicans SC5314, whereas yeast cells from the remaining three isolates (98-277, 95-677 and 94-234) were smaller with ovoid, narrow and elongated shapes (Fig. 1 ). These differences in blastospore morphology were used as a trait to categorize the uncommon isolates into two groups: group I included the three isolates 98-277, 95-677 and 94-234, whilst the remaining six were allocated to group II.
Group II isolates were found to produce germ tubes in 10 % FBS and abundant chlamydospores on Staib agar, Pal agar, Corn meal agar or Casein agar. In contrast, group I isolates were unable to form germ tubes even when exposed to 100 % FBS. In addition, the latter isolates did not form chlamydospores in the above-mentioned media (Fig. 2) nor even in YNB medium supplemented with galactose and methionine (25 mg l 21 ), which has been formulated as a suitable medium for inducing abundant chlamydospores formation in C. dubliniensis, but not in C. Germ tube 
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The results obtained by culturing the test isolates on chromogenic media are illustrated in Fig. 3 . The colony colours of isolates grown on CAC medium were compared with the dark-green colour characteristic of C. dubliniensis and with the light-green colour of C. albicans, which were used as controls. Group I isolates developed different tones of green, whilst the remaining unusual strains formed yellowish-white or pink colonies on this medium. Assays were also performed on CH-P medium plates where C. dubliniensis isolates produce rough bluish-green colonies, whereas most of C. albicans isolates usually grow as smooth light-green colonies (Sahand et al., 2005 (Sahand et al., , 2009 ). On this medium, group I isolates yielded different shades of bluishgreen and light-green smooth colonies, whereas group II isolates developed pink rough colonies.
On ChromID agar most of C. albicans colonies appear cobalt blue, whilst C. dubliniensis isolates form turquoise colonies. However, whilst group I isolates developed turquoise and bluish-white colonies, the remaining six unusual isolates grew as white colonies.
On SDA agar supplemented with phloxine B (SDA-phloxine B), the unusual isolates and reference strains displayed distinct colonial phenotypic variants (Fig. 3) . All the colonies examined reached a similar size with varied colours and textures, except for isolate 94-234 which exhibited the smallest colonies. Group II isolates showed a rather homogeneous phenotype with mostly smooth pink coloured colonies. In contrast, the colonies of group I isolates were more diverse, with smooth, rough or wrinkled colonies (strain 95-677), colours from pale to dark pink and sometimes differential sectors in the same colony (strain 98-277) reminiscent of the white-opaque transition.
The following API/ID32C codes were obtained for the nine unusual isolates: 7142140015, 7142100215, 7143140015 and 7342140015. All of these codes have been described previously for isolates of C. dubliniensis. As with most C. dubliniensis strains, our test isolates were unable to assimilate methyl-a-D-glucoside, lactate, trehalose or xylose, with the exceptions of the 94-234 isolate, which was able to use trehalose as carbon source, and the six uncommon isolates of group II, which were able to grow on lactate. However, these data strongly suggest that the nine unusual isolates are C. dubliniensis.
Immunological characteristics
Bichro-Dubli Fumouze (Marot-Leblond et al., 2006) is a commercial latex agglutination assay based on the specificity of mAb 12F7-F2 to bind to C. dubliniensis cells and not to other Candida spp., thus allowing an easy identification of C. dubliniensis amongst clinical isolates. Whilst the group II isolates yielded a positive reaction using this test, the three group I isolates were negative. The reactivity of mAb 12F7-F2 with the uncommon isolates was further examined by indirect immunofluorescence microscopy using a purified preparation of this antibody. As expected, group II isolates emitted intense fluorescence under the microscope, whereas group I isolates were not labelled by mAb 12F7-F2. However, all group I isolates emitted strong fluorescence after reacting with a C. albicans-adsorbed polyclonal antiserum raised in a rabbit experimentally infected with C. dubliniensis NCPF 3949 (Bikandi et al., 1998) , whilst the reactivity of group II isolates was heterogeneous (Table 2) .
Genotypic characteristics
Results from genotypic analysis assays are summarized in Table 2 . PCR amplification of the HWP1 gene yielded a 569 bp DNA fragment for all the test samples as well as for the C. dubliniensis reference strain (Fig. 4) , whilst the reference C. albicans amplicon size was 941 bp. The identity of the atypical strains as C. dubliniensis was confirmed by multiplex PCR on the basis of differences in their ITS region and topoisomerase II gene, that allowed for the identification of C. albicans and C. dubliniensis isolates simultaneously. The amplified DNA fragments of all the unusual isolates were similar in size to the 816 bp amplicon obtained for the C. dubliniensis reference strain. By sequencing the D1/D2 domain of the large subunit rRNA we obtained three sequences corresponding to the group I isolates, which are now available under GenBank accession numbers KF537273, KF537274 and KF537275. As a result of comparative sequence analyses, the unusual isolates displayed 99 % homology to C. dubliniensis sequences stored in GenBank. The analysis of genotypes by the method of Gee et al. (2002) revealed that group I isolates belonged to genotype 1, whilst the remaining atypical isolates belonged to genotype 2.
Finally, all the uncommon clinical isolates of C. dubliniensis were characterized as heterozygous MTLaa. Fig. 3 . Representative colonies of the unusual isolates and the reference strains C. dubliniensis NCPF 3949 and C. albicans SC5314 grown on various differential media and under various incubation conditions. CAC and ChromID, 37 6C for 48 h; CH-P, 30 6C for 72 h; SDA-phloxine B, 37 6C for 9-10 days. 
O. Albaina and others
Susceptibility to antifungal drugs Table 3 shows the MIC values corresponding to the uncommon isolates under study for the eight antifungal drugs offered by the Sensititre YeastOne 8 system.
According to the Clinical and Laboratory Standards
Institute (2008) guidelines and recommended cut-off values, all the uncommon isolates were categorized as 'susceptible' to the set of antifungal drugs tested. Interestingly, when compared with the reference strain C. dubliniensis NCPF 3949, the uncommon isolates displayed even increased susceptibility to fluconazole and amphotericin B; in particular, group I isolates were the most susceptible to amphotericin B (MIC 0.06-0.128 mg ml
21
) and those of group II to fluconazole (MIC 0.25 mg ml 21 ) together with strain 95-677.
DISCUSSION
The identification of Candida species with a simple, specific and cost-effective assay is essential in medical mycology laboratories in order to achieve a rapid diagnosis and to initiate a suitable antifungal therapy as soon as possible. In a population of 477 clinical isolates which were grown on CAC medium, 434 isolates were identified as C. albicans, 34 as C. dubliniensis and nine isolates yielded anomalous results when subjected to phenotypic analysis. Whilst some phenotypic tests generated ambiguous results, 'gold-standard' DNA analysis by PCR amplification methods based on differences in the sequences of HWP1 and topoisomerase II genes, and sequence analysis of the D1/D2 domain of the large subunit rRNA gene, permitted the definitive identification of the nine isolates as Candida dubliniensis. Other authors have previously reported the specificity and suitability of these methods to identify clinical isolates of C. dubliniensis (BoscoBorgeat et al., 2011; Gasparoto et al., 2009; Khlif et al., 2009; Marcos-Arias et al., 2009; Sahand et al., 2009) .
Clearly, some phenotypic tests accurately identified the unusual isolates correctly. Unlike many C. albicans isolates, C. dubliniensis cannot grow on agar media at 45 u C and this condition is a simple phenotype commonly used to discriminate these two Candida species. The inability of all the uncommon isolates to grow at 45 u C suggests that they fit the pattern established for C. dubliniensis. However, this phenotype is not considered conclusive because C. albicans isolates that are unable to grow, or grow poorly, at 45 u C have also been reported (Gales et al., 1999; Kurzai et al., 2000; Pinjon et al., 1998; Schoofs et al., 1997; .
Several complex culture conditions have been developed where C. dubliniensis can induce chlamydospore formation with high efficiency, whilst C. albicans cannot (Mosca et al., 2003; Pal, 1997; Staib & Morschhäuser, 1999; Sullivan et al., 1995) . In such media, group II isolates and the reference C. dubliniensis strain produced abundant chlamydospores, whereas, unexpectedly, group I isolates failed to form these thick-walled spherical structures. Even in a synthetic medium (Citiulo et al., 2009 ) that provides optimal conditions to stimulate abundant chlamydospore formation in C. dubliniensis, the group I isolates still failed to generate chlamydospores.
In addition, the unusual isolates were able to switch their colony morphology similarly to the white-opaque switching observed for the reference strains of C. dubliniensis and C. albicans. Even more group I isolates seemed to adopt spontaneously aberrant colony morphologies, most likely as a result of a different morphogenetic event based on a second switching system. The suggestive idea that group I isolates are morphogenesis-defective cells harbouring deficiencies in one or more morphogenetic regulatory pathways (Staib & Morschhäauser, 2007 ) cannot be discarded.
Several chromogenic media are now available to differentiate C. albicans from C. dubliniensis. Many authors have verified the suitability of CAC medium to differentiate these two species of the genus Candida on the basis of the green colour produced by their respective colonies (Baumgartner et al., 1996; Bernal et al., 1996; Casal et al., 1997; Coleman et al., 1997a, b; García-Martos et al., 1998; Giusiano & Mangiaterra, 1998; Willinger et al., 2001) . In our hands, group I isolates showed different shades of green colour that hindered their positive identification as C. albicans or C. dubliniensis. Our results for this group of strains are consistent with other reports in the literature (Eraso et al., 2006a; Pincus et al., 1999; Tintelnot et al., 2000) . The remaining uncommon isolates (group II) developed pink colonies, which is inconsistent with either C. albicans or C. dubliniensis. To our knowledge, only Odds & Davidson (2000) had previously described some C. albicans isolates that formed pink coloured colonies on CAC medium. It has been reported that differentiation between C. dubliniensis and C. albicans clinical isolates can be improved in CH-P agar (Sahand et al., 2005 (Sahand et al., , 2009 ); however, in our hands both media, CH-P and CAC, lacked discriminatory capacity to distinguish both Candida species accurately when dealing with these unusual isolates. Finally, ChromID medium has high sensitivity and specificity to differentiate C. dubliniensis from C. albicans (Eraso et al., 2006b) . In this medium, group I isolates resembled the C. dubliniensis reference strain, whilst group II isolates grew anomalously as white colonies. Interestingly, Eraso et al. (2006a) have previously described C. dubliniensis isolates showing white coloured colonies on this medium.
The single phenotypic test which enabled a clear differentiation of the nine uncommon isolates and could be useful for strain identification was the commercial API/ ID32C system based on differences in carbohydrate assimilation profiles. All the numerical profiles recorded for the uncommon isolates had already been described for C. dubliniensis strains (Cárdenes-Perera et al., 2004; Moran et al., 1997) .
Based on phenotypic tests, it is clear that group II isolates should be classified as C. dubliniensis; however, the identity of the group I isolates could be considered inconclusive, suggesting that, with the exception of API/ID32C, phenotypic tests may be illustrative but not conclusive for the differentiation between C. dubliniensis and C. albicans (Gales et al., 1999; Silveira-Gomes et al., 2011) .
The immunoagglutination Bichro-Dubli Fumouze test indicated that group II isolates should be classified as C. dubliniensis, but group I isolates should not (Sahand et al., 2006) . This classification was in accordance with the immunofluorescence microscopy assay developed with a purified preparation of mAb 12F7-F2. However, all the isolates categorized as group I showed intense reactivity with a rabbit polyclonal anti-C.-dubliniensis-specific antiserum, confirming their identity as this species. This behaviour may be due to its polyclonal nature, recognizing antigens different to that specific for mAb 12F7-F2. Furthermore, regarding the extremely weak reaction of group I isolates with mAb 12F7-F2, and their inability to form chlamydospores and germ tubes, a hypothetical relation between the specific antigen recognized by the mAb (Marot-Leblond et al., 2006) and the switching process of C. dubliniensis cannot be discarded. As the cells of group I isolates grown in liquid culture are not typical ovoid yeast cells, it is possible that these cells represent a switched form, perhaps similar to C. albicans opaque cells. If so, it may be possible that the antigen recognized by mAb 12F7-F2 is only present on normal ovoid yeast cells and absent from the surface of switched derivatives, such as the group I isolates. Altogether, the results of immunological assays are not conclusive and the most reliable approach to identify these atypical isolates was obtained with molecular methods of DNA analysis. These methods also enabled further characterization of the nine uncommon isolates, providing relevant data for C. dubliniensis epidemiology. Thus, group I isolates belonged to genotype 1, which is the most common amongst C. dubliniensis isolates (Gee et al., 2002) , whilst group II isolates belonged to genotype 2, which ranked second in frequency (Brena et al., 2004; Gee et al., 2002) . In addition, the nine strains were classified as heterozygous MTLaa, which is the most common mating type amongst C. dubliniensis and C. albicans strains (Pujol et al., 2004) .
In summary, the presence of atypical fungal isolates in clinical samples and their appearance as false-negative results in various identification assays used for routine analysis in the clinical mycology laboratory reinforce the necessity of performing molecular methods of DNA analysis to ascertain the identity of fungal isolates, including the uncommon ones. Fortunately, whilst these atypical isolates may represent a diagnostic challenge, as they are all susceptible to the most commonly used antifungal agents they do not represent a therapeutic challenge as well.
